Glenmark Pharma
BSE: 532296
|
NSE: GLENMARK
Glenmark Pharma
(CIN: L24299MH1977PLC019982)
operates in the Pharmaceuticals industry and has been listed in the stock market since 10 Feb 2000.
It currents trades on NSE with symbol GLENMARK and on BSE with scrip code 532296.
The registered office of the company is B2, Mahalaxmi Chambers, 22, Bhulabhai Desai Road, Mumbai, Maharashtra - 400026.
The management team of Glenmark Pharma is led by GLENN MARIO SALDANHA who is the Executive Director-Chairperson related to Promoter-CEO-MD. Other members of the management team consist of BLANCHE ELIZABETH SALDANHA (Designation:Non-Executive - Non Independent Director), CHERYLANN MARIA PINTO (Designation:Executive Director), SAIRA RAMASASTRY (Designation:Non-Executive - Independent Director), DIPANKAR BHATTACHARJEE (Designation:Non-Executive - Independent Director), VIJAYALAKSHMI RAJARAM IYER (Designation:Non-Executive - Independent Director), PRADEEP KUMAR SINHA (Designation:Non-Executive - Independent Director), ANURAG MANTRI (Designation:Executive Director), PATRICIA ANDREWS (Designation:Non-Executive - Independent Director), Harish Kuber (Designation:Company Secretary & Compliance Officer), .
The price and other financial information of Glenmark Pharma is as below -
The registered office of the company is B2, Mahalaxmi Chambers, 22, Bhulabhai Desai Road, Mumbai, Maharashtra - 400026.
The management team of Glenmark Pharma is led by GLENN MARIO SALDANHA who is the Executive Director-Chairperson related to Promoter-CEO-MD. Other members of the management team consist of BLANCHE ELIZABETH SALDANHA (Designation:Non-Executive - Non Independent Director), CHERYLANN MARIA PINTO (Designation:Executive Director), SAIRA RAMASASTRY (Designation:Non-Executive - Independent Director), DIPANKAR BHATTACHARJEE (Designation:Non-Executive - Independent Director), VIJAYALAKSHMI RAJARAM IYER (Designation:Non-Executive - Independent Director), PRADEEP KUMAR SINHA (Designation:Non-Executive - Independent Director), ANURAG MANTRI (Designation:Executive Director), PATRICIA ANDREWS (Designation:Non-Executive - Independent Director), Harish Kuber (Designation:Company Secretary & Compliance Officer), .
The price and other financial information of Glenmark Pharma is as below -
Volume: 9,999.00
M. Cap: 65,610.09
P/E: 61.60
Prev. Close: 2,340.30
Day
52 Wk
Volume: 2,57,072.00
M. Cap: 65,636.90
P/E: 61.60
Prev. Close: 2,340.60
Day
52 Wk
Stock Price Chart
F&O Data
| expiry_date | open_price | high_price | low_price | prev_close | last_price | volume | turnover_lacs | underlying_value |
|---|---|---|---|---|---|---|---|---|
| 26-May-2026 | 2,350.10 | 2,374.00 | 2,322.10 | 2,351.00 | 2,330.00 | 2,326 | 20,464.90 | 2,320.80 |
| 30-Jun-2026 | 2,363.50 | 2,389.00 | 2,335.00 | 2,364.80 | 2,336.60 | 84 | 742.70 | 2,320.80 |
| 28-Jul-2026 | 2,396.40 | 2,396.40 | 2,365.90 | 2,359.00 | 2,367.30 | 4 | 35.66 | 2,320.80 |
| Calls | 26 May 2026 | Puts | ||||||
|---|---|---|---|---|---|---|---|---|
| OI (Delta OI) |
LTP (Change) |
Intrinsic Value | Time Value | Strike Price | Time Value | Intrinsic Value | LTP (Change) |
OI (Delta OI) |
| - |
- |
- | - | 1,700 | -1175 | 1176.35 | 1.35 (-) |
2,175 (-) |
| - |
- |
- | - | 1,800 | -1275.4 | 1276.35 | 0.95 (-0.65) |
7,250 (-27,550) |
| - |
- |
- | - | 1,880 | -1347.3 | 1356.35 | 9.05 (-) |
5,075 (-) |
| - |
- |
- | - | 1,900 | -1374.75 | 1376.35 | 1.60 (-1.40) |
28,275 (-2,175) |
| 1,450 (-) |
480.00 (-) |
0 | 480 | 1,920 | - | - | - |
- |
| - |
- |
- | - | 1,940 | -1414.15 | 1416.35 | 2.20 (-) |
725 (-2,175) |
| - |
- |
- | - | 1,960 | - | - | - |
- |
| 47,850 (-) |
446.60 (-) |
0 | 447 | 2,000 | -1473.2 | 1476.35 | 3.15 (-0.30) |
1,38,475 (-2,900) |
| - |
- |
- | - | 2,020 | -1475.25 | 1496.35 | 21.10 (-) |
2,900 (-) |
| - |
- |
- | - | 2,040 | -1510.65 | 1516.35 | 5.70 (-) |
18,850 (-) |
| - |
- |
- | - | 2,060 | -1524.35 | 1536.35 | 12.00 (-1.30) |
9,425 (-) |
| 20,300 (-) |
350.95 (-) |
0 | 351 | 2,080 | -1547.7 | 1556.35 | 8.65 (-) |
16,675 (-) |
| 10,875 (-) |
201.50 (-) |
0 | 202 | 2,100 | -1570.15 | 1576.35 | 6.20 (-0.05) |
2,29,100 (+1,450) |
| 725 (-) |
336.75 (-) |
0 | 337 | 2,120 | -1587.05 | 1596.35 | 9.30 (-) |
12,325 (-) |
| 6,525 (-) |
153.65 (+3.30) |
0 | 154 | 2,140 | -1607.7 | 1616.35 | 8.65 (-0.30) |
85,550 (-2,900) |
| - |
- |
- | - | 2,160 | -1624.8 | 1636.35 | 11.55 (-10.95) |
61,625 (+3,625) |
| - |
- |
- | - | 2,180 | -1642.7 | 1656.35 | 13.65 (-0.05) |
28,275 (-) |
| 96,425 (-725) |
144.10 (-25.95) |
0 | 144 | 2,200 | -1658.85 | 1676.35 | 17.50 (+1.60) |
2,30,550 (+26,100) |
| - |
- |
- | - | 2,220 | -1675.35 | 1696.35 | 21.00 (+1.30) |
38,425 (+725) |
| 35,525 (-725) |
108.60 (+11.15) |
0 | 109 | 2,240 | -1690.75 | 1716.35 | 25.60 (+1.95) |
1,10,925 (+11,600) |
| 78,300 (-) |
107.95 (-15.75) |
0 | 108 | 2,260 | -1705.05 | 1736.35 | 31.30 (+2.40) |
86,275 (+1,450) |
| 63,800 (-) |
109.75 (-0.65) |
0 | 110 | 2,280 | -1716.2 | 1756.35 | 40.15 (+5.65) |
64,525 (-2,175) |
| 3,31,325 (+23,925) |
78.00 (-18.90) |
0 | 78 | 2,300 | -1729.85 | 1776.35 | 46.50 (+4.10) |
2,34,900 (+22,475) |
| 1,19,625 (-24,650) |
66.35 (-18.35) |
0 | 66 | 2,320 | -1740 | 1796.35 | 56.35 (+5.00) |
1,02,950 (+18,850) |
| 4,74,150 (+73,950) |
58.90 (-15.30) |
0 | 59 | 2,340 | -1749.7 | 1816.35 | 66.65 (+6.15) |
1,66,025 (-81,925) |
| 3,50,175 (+1,25,425) |
50.00 (-14.70) |
0 | 50 | 2,360 | -1756.85 | 1836.35 | 79.50 (+9.35) |
1,74,725 (+21,750) |
| 1,41,375 (+2,900) |
41.50 (-14.25) |
0 | 42 | 2,380 | -1765.35 | 1856.35 | 91.00 (+9.50) |
1,31,225 (-725) |
| 14,55,800 (-4,350) |
37.10 (-11.50) |
0 | 37 | 2,400 | -1771.85 | 1876.35 | 104.50 (+10.20) |
3,62,500 (-13,050) |
| 1,63,850 (+2,900) |
29.20 (-12.65) |
0 | 29 | 2,420 | -1783.35 | 1896.35 | 113.00 (+6.70) |
1,05,125 (-1,450) |
| 2,80,575 (+1,28,325) |
26.00 (-9.80) |
0 | 26 | 2,440 | -1757.5 | 1916.35 | 158.85 (-) |
1,17,450 (-) |
| 2,26,200 (-97,150) |
22.00 (-8.95) |
0 | 22 | 2,460 | -1804.4 | 1936.35 | 131.95 (+3.15) |
47,125 (-) |
| 2,91,450 (+1,01,500) |
19.55 (-6.50) |
0 | 20 | 2,480 | - | - | - |
- |
| 5,20,550 (-51,475) |
16.35 (-6.50) |
0 | 16 | 2,500 | -1798.75 | 1976.35 | 177.60 (+5.65) |
66,700 (+1,450) |
| 83,375 (+23,200) |
13.80 (-5.75) |
0 | 14 | 2,520 | - | - | - |
- |
| 45,675 (+8,700) |
11.90 (-4.45) |
0 | 12 | 2,540 | - | - | - |
- |
| 51,475 (-7,250) |
10.45 (-3.75) |
0 | 10 | 2,560 | -1750.2 | 2036.35 | 286.15 (-) |
22,475 (-) |
| 31,175 (-) |
9.20 (+1.65) |
0 | 9 | 2,580 | - | - | - |
- |
| 3,53,075 (+38,425) |
8.00 (-2.70) |
0 | 8 | 2,600 | -1850.75 | 2076.35 | 225.60 (-) |
7,250 (-) |
| 67,425 (-33,350) |
6.95 (-2.10) |
0 | 7 | 2,620 | - | - | - |
- |
| 42,050 (-) |
9.55 (-) |
0 | 10 | 2,640 | - | - | - |
- |
| 69,600 (-1,02,950) |
5.45 (+1.60) |
0 | 5 | 2,660 | -1815.45 | 2136.35 | 320.90 (-) |
725 (-) |
| 66,700 (-24,650) |
5.20 (-0.25) |
0 | 5 | 2,680 | - | - | - |
- |
| 98,600 (-3,625) |
4.05 (-) |
0 | 4 | 2,720 | - | - | - |
- |
Shareholding Pattern
| Category | No. of shares | Percent(%) |
|---|---|---|
| Promoters | 13,16,52,682 | 46.65 |
| Pledge | 0 | 0.00 |
| Foreign Institutions | 5,74,13,527 | 20.35 |
| Financial Institutions | 5,42,35,607 | 19.22 |
| NBFC and Mutual Funds | 4,74,04,903 | 16.80 |
| Others | 3,88,98,993 | 13.78 |
| Total | 32,96,05,712 | 116.8 |
NSE Trade Data
| VWAP | 2,339.32 |
| Face Value | 1.00 |
| Traded Volume (shares) | 2.57 |
| Traded Value (lacs) | 60.14 |
| Free Float Market Cap (Crs) | 348.46 |
| 52 week high | 2,474.00 |
| 52 week low | 1,370.00 |
| Lower Price Band | 2,106.60 |
| Upper Price Band | 2,574.60 |
Security-wise Delivery Position
| Quantity Traded | 2,57,072.00 |
| Deliverable Quantity (gross across client level) | 1,01,498.00 |
| % of Deliverable Quantity to Traded Quantity | 39.48 % |
Value at Risk (VaR in %)
| Security VaR | 11.94 |
| Index VaR | - |
| VAR Margin | 11.94 |
| Extreme Loss Rate | 3.50 |
| Adhoc Margin | - |
| Applicable Margin Rate | 15.44 |
Financial Data
Consolidated
| Figures in crore | 2025 | 2024 | 2023 |
|---|---|---|---|
| Net Sales | 13,321.74 | 11,813.10 | 11,583.24 |
| Operating Profit | 2,092.29 | 1,531.70 | 1,625.01 |
| Other Income | 113.72 | 1,237.32 | 755.86 |
| Interest | 207.07 | 515.97 | 349.04 |
| Depreciation | 486.01 | 581.91 | 569.17 |
| Profit Before Tax | 1,399.21 | 433.82 | 706.80 |
| Tax | 352.07 | 1,867.34 | 329.40 |
| Profit After Tax | 1,047.14 | -1,433.52 | 377.40 |
| Share Capital | 28.22 | 28.22 | 28.22 |
| Reserves | 8,821.22 | 7,819.71 | 9,445.71 |
| Net Worth | 8,849.44 | 7,847.93 | 9,473.93 |
| Loans | 2,948.63 | 1,771.45 | 5,005.47 |
| Gross Block | 10,364.92 | 9,619.64 | 10,359.59 |
| Investments | 56.36 | 789.66 | 44.57 |
| Cash | 1,705.23 | 1,659.46 | 1,160.30 |
| Debtors | 3,341.95 | 1,858.41 | 3,665.17 |
| Net Working Capital | 6,419.69 | 3,957.28 | 8,188.76 |
| Operating Profit Margin (%) | 15.71 | 12.97 | 14.03 |
| Net Profit Margin (%) | 7.86 | -12.14 | 3.26 |
| EPS | 37.11 | -53.21 | 10.53 |
| Dividend (%) | 250.00 | 250.00 | 250.00 |
| Dividend Payout | 70.55 | 70.54 | 70.54 |
Standalone
| Figures in crore | 2025 | 2024 | 2023 |
|---|---|---|---|
| Net Sales | 9,226.41 | 7,891.12 | 8,220.66 |
| Operating Profit | 2,421.38 | 7,480.02 | 1,962.85 |
| Other Income | 356.37 | 6,238.36 | 985.94 |
| Interest | 48.73 | 277.11 | 206.82 |
| Depreciation | 218.63 | 202.16 | 184.15 |
| Profit Before Tax | 2,154.02 | 7,000.75 | 1,571.88 |
| Tax | 543.67 | 1,833.46 | 363.11 |
| Profit After Tax | 1,610.35 | 5,167.29 | 1,208.77 |
| Share Capital | 28.22 | 28.22 | 28.22 |
| Reserves | 24,475.74 | 22,942.40 | 17,849.25 |
| Net Worth | 24,503.96 | 22,970.62 | 17,877.47 |
| Loans | 961.89 | 839.23 | 3,593.80 |
| Gross Block | 3,743.15 | 3,392.75 | 3,183.65 |
| Investments | 15,194.91 | 12,964.79 | 10,334.01 |
| Cash | 132.74 | 129.15 | 93.79 |
| Debtors | 2,550.16 | 2,484.47 | 2,505.66 |
| Net Working Capital | 8,137.20 | 8,891.16 | 9,218.96 |
| Operating Profit Margin (%) | 26.24 | 94.79 | 23.88 |
| Net Profit Margin (%) | 17.45 | 65.48 | 14.70 |
| Earning Per Share (Rs) | 57.07 | 183.11 | 42.84 |
| Dividend (%) | 250.00 | 250.00 | 250.00 |
| Dividend Payout | 70.55 | 70.54 | 70.54 |
Dividend Declared (₹)
The company has declared dividend 5 times between 12 Sep 2022 and 03 Oct 2025, totaling Rs. 10.00 so far. The most recent dividend was declared on 03 Oct 2025 for Rs. 2.5.
Financial Data Graph
The peers of Glenmark Pharma are SUNPHARMA, ALKEM and ZYDUSLIFE. You can get more detailed information on those company by clicking on the respective names.
* The above data is collected from public sources and we do not guarantee the accuracy of the same.*
Popular Comments
No comment posted for this article.